High relapse rate among lepromatous leprosy patients treated with rifampin plus ofloxacin daily for 4 weeks.

Fifty-one lepromatous leprosy patients, all of whom had relapsed after previous dapsone (DDS) monotherapy, were treated between 1990 and 1991 with 600 mg of rifampin (RMP) plus 400 mg of ofloxacin (OFLO) daily for 4 weeks, and the great majority of the patients were followed up at least once a year...

Fuld beskrivelse

Bibliografiske detaljer

Udgivet i:	Antimicrob Agents Chemother
Principais autores:	Ji, B, Jamet, P, Sow, S, Perani, E G, Traore, I, Grosset, J H
Format:	Artigo
Sprog:	Inglês
Udgivet:	American Society for Microbiology (ASM) 1997
Fag:	Research Article
Online adgang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC164043/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9303392/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.41.9.1953
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!